Biodel Inc. (Nasdaq: BIOD) today announced that the FDA has granted orphan drug designation for Biodel's 'glucagon' for the prevention ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE